Arkolith/Insider Trading/SGTX/Form 4

Flagship Pioneering Special Opportunities Fund II, L.P.

10% OwnerSigilon Therapeutics, Inc. (SGTX) · full profile →Form 4 · filed Aug 15, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Tender(U)114K$14.92$1.7M0
Aug 11, 2023Tender(U)684K$14.92$10.2M0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-018154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML